Vivos CARE Oral Medical Devices Proven to Enhance Airways by Redeveloping Dental Arch Forms and Jaws. LITTLETON, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc.
More than 80% of patients implanted with a transvenous phrenic nerve stimulation device for central sleep apnea had at least ...
Nearly a quarter of people in a global analysis of Samsung Health users showed indicators associated with sleep apnea risk, ...
Sleep apnea breakthrough: Clinical trial finds drug sulthiame may reduce night-time breathing pauses
Obstructive sleep apnea occurs when the upper airway repeatedly collapses during sleep, temporarily blocking airflow ...
2dOpinion
The Cure for Snoring
Regular snoring becomes more likely as you age. For me, the condition seems to have emerged about five years ago, in my early ...
Morning Overview on MSN
Trial: Sulthiame pill cut sleep apnea breathing interruptions by 50%
A once-daily pill called sulthiame cut breathing interruptions during sleep by up to 47 percent in adults with obstructive ...
Researchers conduct the first meta-analysis comparing hypnotics in OSA patients, finding most are safe but flagging temazepam ...
Snoring every night? It might be more than just fatigue. Medical experts warn that habitual snoring can signal Sleep Apnea, a ...
Snoring is the 'hallmark of sleep apnea', a doctor says, but there are other signs and metrics to look for on your sleep ...
A recent clinical trial, conducted in 2023, showed promising results for the medication sulthiame, which may reduce breathing interruptions in people with sleep apnea. The ...
A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.
In patients with OSA, increased subjective sleepiness based on ESS scores is associated with higher short-term CPAP adherence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results